122 related articles for article (PubMed ID: 3962658)
1. Normal growth of nephrotic children during long-term alternate-day prednisone therapy.
Polito C; Oporto MR; Totino SF; La Manna A; Di Toro R
Acta Paediatr Scand; 1986 Mar; 75(2):245-50. PubMed ID: 3962658
[TBL] [Abstract][Full Text] [Related]
2. Delayed pubertal growth spurt in glomerulopathic boys receiving alternate-day prednisone.
Polito C; Di Toro R
Child Nephrol Urol; 1992; 12(4):202-7. PubMed ID: 1473093
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide in treatment of minimal change nephrotic syndrome.
Shohet I; Meyerovitch J; Aladjem M; Boichis H
Eur J Pediatr; 1988 Apr; 147(3):239-41. PubMed ID: 3391218
[TBL] [Abstract][Full Text] [Related]
4. Treatment of the nephrotic syndrome in childhood. Use of an alternate-day prednisone regimen.
Soyka LF
Am J Dis Child; 1967 Jun; 113(6):693-701. PubMed ID: 6025079
[No Abstract] [Full Text] [Related]
5. Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation.
Broyer M; Guest G; Gagnadoux MF
J Pediatr; 1992 May; 120(5):721-5. PubMed ID: 1578306
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral content in nephrotic children on long-term, alternate-day prednisone therapy.
Polito C; La Manna A; Todisco N; Cimmaruta E; Sessa G; Pirozzi M
Clin Pediatr (Phila); 1995 May; 34(5):234-6. PubMed ID: 7628164
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of children with steroid-responsive nephrotic syndrome.
Siegel NJ; Goldberg B; Krassner LS; Hayslett JP
J Pediatr; 1972 Aug; 81(2):251-8. PubMed ID: 4339533
[No Abstract] [Full Text] [Related]
8. Alternate-day steroids affect carpal maturation more than radius, ulna and short bones.
Polito C; Greco N; Opallo A; Cimmaruta E; La Manna A
Pediatr Nephrol; 1994 Aug; 8(4):480-2. PubMed ID: 7947042
[TBL] [Abstract][Full Text] [Related]
9. Statural growth and skeletal maturation in rheumatic prepubertal children treated with a third generation glucocorticoid (deflazacort) versus prednisone. An interim study.
Vignolo M; Milani S; Imbimbo B; Naselli A; Di Battista E; Piaggio G; Leveratto L; Morreale G; Sardella ML; Corsini M
Clin Exp Rheumatol; 1991; 9 Suppl 6():41-5. PubMed ID: 2060177
[TBL] [Abstract][Full Text] [Related]
10. Effect of corticosteroids on growth in children with steroid-sensitive nephrotic syndrome.
Ekim M; Tümer N; Ocal G; Yalçinkaya F; Ensari C; Cakar N
Child Nephrol Urol; 1992; 12(1):10-4. PubMed ID: 1606574
[TBL] [Abstract][Full Text] [Related]
11. The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome.
Dinçel N; Yılmaz E; Kaplan Bulut İ; Hacıkara Ş; Mir S
Ren Fail; 2015; 37(8):1267-72. PubMed ID: 26313331
[TBL] [Abstract][Full Text] [Related]
12. Daily single-dose and daily reduced-dose prednisone therapy for children with the nephrotic syndrome.
Warshaw BL; Hymes LC
Pediatrics; 1989 May; 83(5):694-9. PubMed ID: 2717285
[TBL] [Abstract][Full Text] [Related]
13. Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis.
Lai HC; FitzSimmons SC; Allen DB; Kosorok MR; Rosenstein BJ; Campbell PW; Farrell PM
N Engl J Med; 2000 Mar; 342(12):851-9. PubMed ID: 10727589
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children.
Tejani A; Suthanthiran M; Pomrantz A
Nephron; 1991; 59(1):96-9. PubMed ID: 1944755
[TBL] [Abstract][Full Text] [Related]
15. Normal growth of prepubertal nephrotic children during long-term treatment with repeated courses of prednisone.
Saha MT; Laippala P; Lenko HL
Acta Paediatr; 1998 May; 87(5):545-8. PubMed ID: 9641737
[TBL] [Abstract][Full Text] [Related]
16. Effects of repeated courses of daily steroids and of persistent proteinuria on linear growth in children with nephrotic syndrome.
Adhikari M; Manikkam NE; Coovadia HM
Pediatr Nephrol; 1992 Jan; 6(1):4-9. PubMed ID: 1536738
[TBL] [Abstract][Full Text] [Related]
17. Growth after renal transplantation in prepubertal children: impact of various treatment modalities.
Hokken-Koelega AC; Van Zaal MA; de Ridder MA; Wolff ED; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Drop SL
Pediatr Res; 1994 Mar; 35(3):367-71. PubMed ID: 8190529
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation.
Aicardi G; Benso L; Vignolo M; Terragna A; Verrina E; Cordone G; Coppo R; Sernia O; Sardella ML; Di Battista E
Br J Rheumatol; 1993 May; 32 Suppl 2():39-43. PubMed ID: 8495279
[TBL] [Abstract][Full Text] [Related]
19. The fate of children with nephrotic syndrome in the light of the author's material.
Derulska D; Wojnarowski M
Pol Med J; 1970; 9(6):1368-73. PubMed ID: 5505050
[No Abstract] [Full Text] [Related]
20. Growth of asthmatic children during treatment with alternate-day steriods.
Reimer LG; Morris HG; Ellis EF
J Allergy Clin Immunol; 1975 Apr; 55(4):224-31. PubMed ID: 1123495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
